Showing results (111-120 of 164) with videos related to
Sort By:
Pageof 17
Breast Cancer Research and Treatment|January 1, 1992
Cytosol cathepsin-D content and proliferative activity of human breast cancer. The Comitato Italiano per il Controllo di Qualita del Laboratorio in OncologiaA Paradiso, A Mangia, M Correale, et al.Leukemia & Lymphoma|August 1, 1994
Prognostic factors and survival in non-Hodgkin's lymphomas: the experience of the Istituto Oncologico Romagnolo (IOR)E Pasquini, M Nicolini, G Rosti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 17, 2005
RT-PCR determination of maspin and mammaglobin B in peripheral blood of healthy donors and breast cancer patientsL Mercatali, V Valenti, D Calistri, et al.Cancer Research|June 1, 1993
Base transitions are the most frequent genetic changes at P53 in gastric cancerB Renault, M van den Broek, R Fodde, et al.Cancer|August 30, 2000
Impact of delirium on the short term prognosis of advanced cancer patients. Italian Multicenter Study Group on Palliative CareA Caraceni, O Nanni, M Maltoni, et al.Tumori|August 9, 2003
[Adjuvant adoptive immunotherapy in patients with stage III and resected stage IV melanoma: a pilot study]G M Verdecchia, L Ridolfi, R Ridolfi, et al.Breast Cancer Research and Treatment|January 1, 1991
An efficient method for culturing human breast carcinoma to evaluate antiblastic drug activity in vitro: experience on 136 primary cancers and on 116 recurrencesW Zoli, A Volpi, C Bonaguri, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Conventional versus cytokinetic polychemotherapy with estrogenic recruitment in metastatic breast cancer: results of a randomized cooperative trialP F Conte, P Pronzato, A Rubagotti, et al.Breast Cancer Research and Treatment|December 1, 1993
Establishment and characterization of a new cell line from primary human breast carcinomaD Amadori, L Bertoni, A Flamigni, et al.Cancer Research|May 15, 1990
Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cellsH S Smith, W Zoli, A Volpi, et al.Pageof 17